Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy

Conclusion Although there was a trend toward greater subjective improvement in overall symptoms with amitriptyline, interpretation is limited due to the small sample size. Larger randomized controlled trials to determine the efficacy of neuro-modulating agents in the treatment of chronic laryngopharyngeal neuropathy, as well as better metrics to characterize this disorder, are warranted.
Source: American Journal of Otolaryngology - Category: Endocrinology Source Type: research